Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

JNJ | Johnson & Johnson

Healthcare | Drug Manufacturers - General | USA | NYSE

Index	DJIA, S&P 500	P/E	31.50	EPS (ttm)	4.94	Insider Own	0.18%	Shs Outstand	2.61B	Perf Week	-1.01%
Market Cap	374.49B	Forward P/E	14.23	EPS next Y	10.93	Insider Trans	-1.08%	Shs Float	2.40B	Perf Month	-3.21%
Income	13.05B	PEG	5.48	EPS next Q	2.53	Inst Own	76.60%	Short Float / Ratio	0.93% / 0.99	Perf Quarter	-3.76%
Sales	97.81B	P/S	3.83	EPS this Y	0.35%	Inst Trans	-0.39%	Short Interest	22.26M	Perf Half Y	-1.87%
Book/sh	28.92	P/B	5.38	EPS next Y	7.26%	ROA	7.07%	Target Price	180.26	Perf Year	-4.71%
Cash/sh	11.84	P/C	13.14	EPS next 5Y	5.75%	ROE	17.23%	52W Range	150.11 - 181.04	Perf YTD	-11.96%
Dividend	4.63	P/FCF	25.74	EPS past 5Y	70.31%	ROI	11.97%	52W High	-14.10%	Beta	0.57
Dividend %	2.97%	Quick Ratio	0.88	Sales past 5Y	4.55%	Gross Margin	67.59%	52W Low	3.60%	ATR	2.24
Employees	152700	Current Ratio	1.12	Sales Q/Q	6.27%	Oper. Margin	26.37%	RSI (14)	30.03	Volatility	1.17% 1.27%
Optionable	Yes	Debt/Eq	0.61	EPS Q/Q	8.57%	Profit Margin	13.35%	Rel Volume	0.22	Prev Close	155.34
Shortable	Yes	LT Debt/Eq	0.45	Earnings	Oct 17 BMO	Payout	66.07%	Avg Volume	22.53M	Price	155.52
Recom	2.43	SMA20	-2.90%	SMA50	-6.06%	SMA200	-4.79%	Volume	4,955,002	Change	0.12%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-06-23	Initiated	HSBC Securities	Hold	$175
May-30-23	Resumed	Citigroup	Buy	$185
Mar-29-23	Initiated	UBS	Neutral	$164
Mar-01-23	Initiated	Guggenheim	Neutral	$161
Nov-18-22	Initiated	Credit Suisse	Neutral	$170
Oct-18-22	Initiated	Barclays	Equal Weight	$175
Oct-14-22	Reiterated	BofA Securities	Neutral	$185 → $178
Jun-22-22	Initiated	Daiwa Securities	Outperform
May-23-22	Resumed	SVB Leerink	Outperform	$200
Apr-06-22	Resumed	Morgan Stanley	Equal-Weight	$173
Mar-16-22	Downgrade	Bernstein	Outperform → Mkt Perform	$180 → $183
Mar-02-22	Resumed	BofA Securities	Neutral	$185
Dec-17-21	Initiated	Goldman	Neutral	$161
Dec-15-21	Reiterated	Citigroup	Buy	$192 → $195
Sep-07-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$187
May-28-21	Resumed	Morgan Stanley	Overweight	$187
Apr-28-20	Downgrade	UBS	Buy → Neutral	$163 → $160
Apr-22-20	Upgrade	BofA/Merrill	Neutral → Buy	$150 → $175
Mar-05-20	Initiated	Citigroup	Buy	$163
Dec-19-19	Upgrade	Barclays	Equal Weight → Overweight	$173

Show Previous Ratings

Today 02:37PM	Palantir And PwC Team Up To Accelerate Data-Driven Operations, OpenAI Rival Secures Billions In Big Tech Backing, Six US States Brace For Healthcare Strike: Today's Top Stories (Benzinga)
02:02PM	14 Best Bear Market Stocks To Buy Now (Insider Monkey)
09:00AM	Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know (Zacks)
Oct-03-23 12:11PM	'Airbnb Has Foundational Cracks', Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft's Nadella Criticizes Google's Exclusive Content Deals: Today's Top Stories (Benzinga)
11:29AM	Behind the new malaria vaccine endorsed by the World Health Organization (Yahoo Finance)
10:45AM	Loading…
10:45AM	Sanofi (SNY) Inks Deal With J&J to Develop E. coli Vaccine (Zacks)
10:08AM	The 10 pharma companies participating in Medicare price negotiations (Yahoo Finance Video)
10:07AM	UPDATE 3-Court tosses $223.8 million verdict against J&J in talc cancer case (Reuters)
09:51AM	Court tosses $223.8 million verdict against J&J in talc cancer case (Reuters)
05:09AM	12 Best Places to Retire in Dominican Republic (Insider Monkey)
01:41AM	Sanofi in agreement with Janssen to develop E. coli the vaccine candidate (Reuters)
01:00AM	Press Release Biocartis Group NV: Disclosure of transparency notification (GlobeNewswire)
Oct-02-23 05:45PM	Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know (Zacks)
10:45AM	J&J's (JNJ) Rybrevant Combo Meets Primary Goal in NSCLC Study (Zacks)
Oct-01-23 06:00AM	Could Kenvue Follow in the Footsteps of Johnson & Johnson and Become a Top Dividend Stock? (Motley Fool)
11:54AM	Loading…
Sep-30-23 11:54AM	15 Warren Buffett Stocks That Are On Sale Now (Insider Monkey)
06:55AM	3 Magnificent Dividend Stocks to Buy in October (Motley Fool)
Sep-29-23 06:41AM	UPDATE 2-Aid agency urges Johnson & Johnson to improve access to tuberculosis drug (Reuters)
05:21AM	These 7 Dividend Stocks Pay $98 Billion Annually, Combined, to Their Shareholders (Motley Fool)
04:35AM	Aid agency urges Johnson & Johnson to improve access to tuberculosis drug (Reuters)
04:31AM	Unitaid urges Johnson & Johnson to improve access to TB drug bedaquiline (Reuters)
02:13AM	Dividend Aristocrats Ranked By Yield: Top 25 (Insider Monkey)
Sep-28-23 03:22PM	Analyst Report: Johnson & Johnson (Morningstar Research)
10:15AM	3 Dividend Kings With Recession-Proof Payouts (TheStreet.com)
07:47AM	UPDATE 3-J&J's lung cancer therapy succeeds in head-to-head study with AstraZeneca's drug (Reuters)
07:35AM	J&J's lung cancer therapy combo succeeds in late-stage study (Reuters)
Sep-27-23 09:12AM	The Kellogg Split (Motley Fool)
05:30AM	3 Things About Johnson & Johnson That Smart Investors Know (Motley Fool)
Sep-26-23 05:45PM	Johnson & Johnson (JNJ) Stock Moves -0.77%: What You Should Know (Zacks)
03:33PM	15 Best Dividend Aristocrat Stocks To Buy Now (Insider Monkey)
12:26PM	Loading…
12:26PM	Novartis' (NVS) Sandoz Gets EC Nod for Tysabri's Biosimilar (Zacks)
07:41AM	2 Monster Stocks to Buy Without Any Hesitation (Motley Fool)
Sep-24-23 12:52PM	Dividend Stock Portfolio: 15 Stocks To Buy According to Reddit (Insider Monkey)
07:41AM	3 Best Stocks to Buy in September and Hold Forever (Motley Fool)
Sep-22-23 03:47PM	20 Most Innovative Companies in America (Insider Monkey)
09:00AM	Here is What to Know Beyond Why Johnson & Johnson (JNJ) is a Trending Stock (Zacks)
Sep-21-23 08:00AM	Blockbuster Cancer Treatment Stymied by Supply Chainfor Now (The Wall Street Journal)
Sep-20-23 02:52PM	Rockville life sciences firm Emmes names former J&J exec Peter Ronco as its new CEO (American City Business Journals)
01:29PM	Consumers seek consolidation of class actions against P&G, Johnson & Johnson over decongestant (American City Business Journals)
06:00AM	Buying These 2 Stocks Is a Good Way to Hedge Against a Market Crash (Motley Fool)
05:21AM	3 No-Brainer Stocks to Buy With $500 Right Now (Motley Fool)
Sep-19-23 05:45PM	Johnson & Johnson (JNJ) Stock Moves -0.17%: What You Should Know (Zacks)
04:25AM	10 Best Investments During A Recession (Insider Monkey)
Sep-18-23 04:30PM	Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results (Business Wire)
08:03AM	The Zacks Analyst Blog Highlights Meta Platforms, Walmart, Johnson & Johnson, Pfizer and Morgan Stanley (Zacks)
Sep-17-23 11:09AM	3 High-Quality Dividend Stocks Yielding 3%-Plus to Buy for Decades of Rising Income (Motley Fool)
Sep-15-23 08:45PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
12:59PM	Top Analyst Reports for Meta Platforms, Walmart & Johnson & Johnson (Zacks)
09:16AM	This J&J exec sold Tylenol and Listerine. Now she runs its $27 billion medtech business (Fortune)
08:26AM	Big Pharma's Johnson & Johnson under investigation in South Africa over 'excessive' drug prices (AP Finance)
08:10AM	3 Great Dividend Stocks You Can Buy for Less Than $50 (Motley Fool)
02:12AM	25 Most Admired Companies in 2023 (Insider Monkey)
Sep-14-23 04:12PM	Johnson & Johnson ditching script logo after 130 years (Fox Business)
02:17PM	UPDATE 3-J&J unit, P&G, Walgreens misled consumers about decongestants--lawsuits (Reuters)
12:52PM	J&J, P&G sued after FDA panel ruling on cold medicine decongestant (Reuters)
10:28AM	At Johnson & Johnson, a New Look but Old Hurdles (The Wall Street Journal)
10:00AM	Johnson & Johnson is getting rid of its script logo after more than 130 years (AP Finance)
10:00AM	Johnson & Johnson Marks New Era as Global Healthcare Company With Updated Visual Identity (Business Wire)
05:20AM	3 Warren Buffett Stocks That Are Near Their 52-Week Lows (Motley Fool)
Sep-13-23 05:45PM	Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know (Zacks)
07:41AM	Here's My Top Growth Stock to Buy in 2023 (Motley Fool)
05:30AM	Better Buy: J&J vs. Kenvue (Motley Fool)
Sep-12-23 05:16PM	12 Best Pharma ETFs (Insider Monkey)
12:05PM	Novartis' (NVS) Sandoz Gets Rights for Stelara Biosimilar (Zacks)
11:49AM	AstraZeneca (AZN) Posts Upbeat Data on Lung Cancer Drug Combo (Zacks)
06:45AM	Bristol Myers, J&J invest in Boston biotech's $72M VC round (American City Business Journals)
Sep-11-23 07:47PM	Doctor asks court to toss J&J lawsuit against her over cancer research (Reuters)
03:30PM	10 Best Dividend ETFs (Insider Monkey)
12:31PM	J&J (JNJ) Seeks Approval for Bladder Cancer Drug in Europe (Zacks)
09:00AM	Is Trending Stock Johnson & Johnson (JNJ) a Buy Now? (Zacks)
06:49AM	Could This Issue Sink Johnson & Johnson's Stock Price? (Motley Fool)
05:21AM	Warren Buffett's Highest-Yielding Stock Isn't Citigroup at 5%. He's Netting Almost 57% Annually From Another Top Holding. (Motley Fool)
Sep-10-23 03:53PM	25 Most Biodiverse Countries in the World (Insider Monkey)
06:00AM	Bargain Hunting With $100? This New S&P 500 Dividend Stock Is a No-Brainer to Buy on the Dip (Motley Fool)
Sep-09-23 08:00AM	Big Pharmas Battle With the Biden Administration Could Have Legs (The Wall Street Journal)
05:00AM	3 No-Brainer Dividend Stocks to Buy No Matter What the Market Is Doing (Motley Fool)
Sep-08-23 07:00PM	AOC Has It Right on CEO David Zaslavs Pay (Barrons.com)
01:29PM	Kenvue, the J&J Healthcare Spinoff, Has Disappointed Investors (TheStreet.com)
Sep-07-23 05:45PM	Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know (Zacks)
05:40PM	Kenvue Stock Falls 6%. It May Be Fears on Tylenol Lawsuits. (Barrons.com)
05:40PM	Kenvue Stock Falls 6% on Apparent Fears on Tylenol Lawsuits (Barrons.com)
01:13PM	Warren Buffett Dividend Stocks by Sectors and Industries (Insider Monkey)
01:06PM	Healthcare Stocks Push the Dow Higher (Barrons.com)
11:36AM	Johnson & Johnson (JNJ): A Modestly Undervalued Gem? (GuruFocus.com)
10:09AM	Dell downgraded to Sell, McDonald's upgraded: Wall Street's top analyst calls (The Fly)
09:05AM	1 Brand-New Dividend Stock Income Investors Won't Want to Miss (Motley Fool)
08:43AM	J&J (JNJ) to End Pulmonary Hypertension Study on Opsumit (Zacks)
Sep-06-23 05:50PM	UPDATE 1-J&J to pull the plug on hypertension drug study (Reuters)
05:21PM	J&J stops hypertension drug study (Reuters)
02:34PM	IBM notifies J&J unit Janssen CarePath's customers of unauthorized data access (Reuters)
11:14AM	12 Best Healthcare ETFs To Buy (Insider Monkey)
07:58AM	UPDATE 2-J&J says drug combo contains lung cancer from spreading for longer duration (Reuters)
07:40AM	J&J lung cancer drug combo meets late-stage study goals (Reuters)
07:03AM	15 Stocks to Buy with Steady Dividends (Insider Monkey)
06:00AM	Is J&J a Buy After the Kenvue Separation? (Motley Fool)
Sep-05-23 12:19PM	Facebook News To Shut Down In Europe, Warner Bros. Discovery Revises Outlook As Strike Bites, Manchester United No Longer Up For Sale: Today's Top Stories (Benzinga)
07:09AM	Short sellers return to profit in August as US stocks rally pauses - Ortex (Reuters)
Sep-04-23 05:30AM	J&Js $40 Billion Split-Off Sets Stage for Pharma, Medical Tech Expansion (The Wall Street Journal)
Sep-03-23 09:45AM	4 Warren Buffett Stocks That Could Join the Trillion-Dollar Club by 2032 (Motley Fool)
07:40AM	Is It Too Late to Buy Veeva Systems Stock? (Motley Fool)

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and MedTech. The Consumer Health segment includes products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women's Health and Wound Care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The MedTech segment offers products used in the interventional solutions. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hait William	See Remarks	Jul 26	Option Exercise	90.44	14,698	1,329,287	102,445	Jul 27 05:52 PM
Hait William	See Remarks	Jul 26	Sale	172.00	14,698	2,528,056	87,747	Jul 27 05:52 PM
Fasolo Peter	Exec VP, Chief HR Officer	Jul 25	Sale	170.32	20,000	3,406,498	102,696	Jul 27 05:52 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Jun 12	Sale	160.00	12,465	1,994,400	65,934	Jun 14 04:19 PM
Swanson James D.	See Remarks	Mar 06	Sale	154.66	1,062	164,199	9,215	Mar 08 04:16 PM
McEvoy Ashley	EVP, WW Chair, MedTech	Feb 10	Option Exercise	0.00	2,999	0	44,812	Feb 14 04:36 PM
Taubert Jennifer L	EVP, WW Chair, Pharmaceuticals	Feb 10	Option Exercise	0.00	3,570	0	130,026	Feb 14 04:36 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 10	Option Exercise	0.00	5,220	0	300,940	Feb 14 04:37 PM
Fasolo Peter	Exec VP, Chief HR Officer	Feb 10	Option Exercise	0.00	2,078	0	116,754	Feb 14 04:35 PM
Mongon Thibaut	Exec VP, WW Chair, Cons Health	Feb 10	Option Exercise	0.00	2,285	0	59,461	Feb 14 04:35 PM
Hait William	See Remarks	Feb 10	Option Exercise	0.00	3,856	0	84,092	Feb 14 04:35 PM
Wolk Joseph J	Exec VP, CFO	Feb 10	Option Exercise	0.00	3,449	0	39,261	Feb 14 04:36 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 10	Option Exercise	0.00	1,807	0	73,118	Feb 14 04:37 PM
Swanson James D.	See Remarks	Feb 10	Option Exercise	0.00	1,291	0	8,355	Feb 14 04:34 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 10	Option Exercise	0.00	1,592	0	17,259	Feb 14 04:35 PM
Decker Robert J	VP Corporate Controller	Feb 10	Option Exercise	0.00	581	0	16,054	Feb 14 04:35 PM
Gorsky Alex	Director	Jan 17	Option Exercise	72.54	547,692	39,729,578	1,133,194	Jan 18 04:39 PM
Duato Joaquin	CEO and Chairman of the Board	Jan 17	Option Exercise	72.54	148,538	10,774,947	394,515	Jan 18 04:39 PM
Wolk Joseph J	Exec VP, CFO	Dec 13	Option Exercise	88.19	14,781	1,303,589	50,593	Dec 15 04:34 PM
Wolk Joseph J	Exec VP, CFO	Dec 13	Sale	179.60	14,781	2,654,661	35,812	Dec 15 04:34 PM
McEvoy Ashley	EVP, WW Chair, MedTech	Nov 30	Option Exercise	72.54	73,323	5,318,850	115,136	Dec 02 04:32 PM
McEvoy Ashley	EVP, WW Chair, MedTech	Nov 30	Sale	175.47	73,323	12,865,801	41,813	Dec 02 04:32 PM
Taubert Jennifer L	EVP, WW Chair, Pharmaceuticals	Nov 22	Option Exercise	72.54	76,923	5,579,994	203,379	Nov 23 04:44 PM
Taubert Jennifer L	EVP, WW Chair, Pharmaceuticals	Nov 22	Sale	176.78	76,923	13,598,402	126,456	Nov 23 04:44 PM
Decker Robert J	Controller, CAO	Nov 18	Option Exercise	90.44	16,928	1,530,968	32,401	Nov 21 04:33 PM
Decker Robert J	Controller, CAO	Nov 18	Sale	175.00	16,928	2,962,400	15,473	Nov 21 04:33 PM
Wengel Kathryn E	EVP, Chief GSC Officer	Nov 09	Option Exercise	72.54	16,410	1,190,381	87,721	Nov 10 04:47 PM
Wengel Kathryn E	EVP, Chief GSC Officer	Nov 09	Sale	173.42	16,410	2,845,773	71,311	Nov 10 04:47 PM
Mongon Thibaut	Exec VP, WW Chair, Consumer	Nov 07	Option Exercise	109.99	17,043	1,874,626	57,176	Nov 09 05:01 PM
Mongon Thibaut	Exec VP, WW Chair, Consumer	Nov 04	Option Exercise	130.77	35,246	4,609,161	75,379	Nov 08 04:59 PM
Mongon Thibaut	Exec VP, WW Chair, Consumer	Nov 04	Sale	171.18	35,246	6,033,305	40,133	Nov 08 04:59 PM
Swanson James D.	EVP, Chief Information Officer	Nov 02	Option Exercise	0.00	9,912	0	10,996	Nov 04 04:30 PM
Fasolo Peter	Exec VP, Chief HR Officer	Oct 24	Option Exercise	115.67	78,458	9,075,237	193,134	Oct 26 07:20 PM
Hait William	See Remarks	Oct 24	Option Exercise	90.44	15,000	1,356,600	95,236	Oct 26 04:51 PM
Fasolo Peter	Exec VP, Chief HR Officer	Oct 24	Sale	171.36	29,275	5,016,623	114,676	Oct 26 07:21 PM
Fasolo Peter	Exec VP, Chief HR Officer	Oct 24	Sale	171.19	20,851	3,569,558	143,951	Oct 26 07:21 PM
Hait William	See Remarks	Oct 24	Sale	171.55	15,000	2,573,220	80,236	Oct 26 04:51 PM
Fasolo Peter	Exec VP, Chief HR Officer	Oct 24	Sale	171.22	12,998	2,225,554	164,802	Oct 26 07:20 PM
Fasolo Peter	Exec VP, Chief HR Officer	Oct 24	Sale	171.14	8,256	1,412,940	177,800	Oct 26 07:20 PM
Fasolo Peter	Exec VP, Chief HR Officer	Oct 24	Sale	171.13	4,263	729,520	184,856	Oct 26 07:20 PM
Fasolo Peter	Exec VP, Chief HR Officer	Oct 24	Sale	171.02	2,815	481,429	188,719	Oct 26 07:20 PM
Fasolo Peter	Exec VP, Chief HR Officer	Oct 19	Option Exercise	101.87	70,126	7,143,736	184,802	Oct 21 04:31 PM
Fasolo Peter	Exec VP, Chief HR Officer	Oct 19	Sale	164.50	29,946	4,926,207	136,240	Oct 21 04:31 PM
Fasolo Peter	Exec VP, Chief HR Officer	Oct 19	Sale	164.50	22,864	3,761,197	114,676	Oct 21 04:31 PM
Fasolo Peter	Exec VP, Chief HR Officer	Oct 19	Sale	164.50	13,703	2,254,185	167,486	Oct 21 04:31 PM
Fasolo Peter	Exec VP, Chief HR Officer	Oct 19	Sale	164.50	3,613	594,349	181,189	Oct 21 04:31 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

JNJ | Johnson & Johnson

Upgrade your FINVIZ experience